[Experimental arrhythmia and its prevention].
The preventive antiarrhythmic effect of a new derivative of selenium-containing aralkyl amines, i. e. selenofen-24, was compared with the routinely used drugs-novocainamide, isoptin and inderal. With respect to the preventive effect and spectrum of action selenofen-24 was shown to be advantageous on various experimental models of arrhythmias: aconitine, strophanthin, pituitrin or calcium chloride.